Login / Signup

Routine measurements of factor VIII activity and inhibitor titer in the presence of emicizumab utilizing anti-idiotype monoclonal antibodies: comment.

Hideo WadaTakeshi MatsumotoYoshiki YamashitaKohshi OhishiMakoto IkejiriNaoyuki Katayama
Published in: Journal of thrombosis and haemostasis : JTH (2019)
Keyphrases
  • clinical practice